Mode
Text Size
Log in / Sign up
N/A N=8 Health Services Research

Clinical Interviews With Detainees With Early Psychosis

First-Episode Psychosis

Enrolled (actual)
8
Serious AEs
0.0%
Results posted
Jun 2023
Primary outcome: Primary: Number of Referrals to Correctional Health Services (CHS) — 8 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Specialized Early Engagement Support Service (Behavioral)
Age
Adult · 18+ yrs
Sex
All
Sponsor
Columbia University
Primary completion
Mar 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Referrals to Correctional Health Services (CHS)
8
PRIMARY
Number of Referrals to Coordinated Specialty Care (CSC)
1

Summary

The investigators are studying a jail-based intervention to reduce the duration of untreated psychosis (DUP) among young adults with previously undetected first-episode psychosis who are detained in jail. Longer DUP (or treatment delay) is linked to poorer outcomes in first-episode psychosis and there is evidence that justice-involved young adults with first-episode psychosis have an alarmingly long DUP. Thus, despite the expansion of Coordinated Specialty Care (CSC) programs that improve outcomes through early, multi-component care, there is a need to establish early detection services in the criminal justice system and create pathways from justice involvement to CSC. This intervention offers a novel and potentially high impact approach for reducing DUP in jail settings: a jail-based Specialized Early Engagement Support Service that receives referrals, engages detainees, and serves as a bridge to community-based CSC. The study team will design and implement the intervention, thoroughly study its feasibility and acceptability, and prepare an intervention manual for broader use in diverse jails and future formal research.

Eligibility Criteria

Inclusion Criteria

  • Detainees that have been referred by Correctional Health Services as experiencing early-course or first-episode psychosis
  • between the ages of 18 and 30 years
  • have a Mini-Mental State Examination (MMSE) score of >23
  • have the capacity to provide informed consent for the study
  • able to understand and speak English

Exclusion Criteria

  • children under the age of 18 years
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03962348). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search